In fact, since intravenous prostacyclin agonists are indicated for severe disease the correlation between levels of IL-10 and intravenous PH target therapy might be biased and it cannot be excluded that levels of IL-10 correlate with the severity of PAH[21,22]. Here, IL10 is linked to pulmonary arterial hypertension.